Press Releases

Poxel Announces its Participation at Patient Association Conferences in Adrenoleukodystrophy

Jun 15, 2023

Poxel Reports Cash and Revenue for the First Quarter 2023 and Provides Corporate Update

May 17, 2023

Poxel Announces Notice of Its Annual General Meeting to Be Held on June 21, 2023

May 16, 2023

Poxel Announces TWYMEEG® (Imeglimin) Fiscal Year 2022 Sales

May 15, 2023

Poxel Announces Upcoming Participation at the JMP Securities Life Science Conference

May 11, 2023

Poxel Announces Availability of the 2022 Universal Registration Document and Provides Update on Accounts Settlement

May 3, 2023

Poxel Announces Multiple TWYMEEG® (Imeglimin) Abstracts Accepted for Oral Presentation

Apr 20, 2023

Poxel Reports Financial Results for Full Year 2022 and Provides Corporate Update

Mar 23, 2023

Poxel Announces Cash Runway Extended Through Q2 2025 Based upon Debt Restructuring Agreement and New Equity-linked Financing Facility

Mar 23, 2023

Poxel will Report its 2022 Full Year Results on March 23, 2023

Mar 22, 2023